Testing effectiveness (Phase 2)Study completedNCT02148133
What this trial is testing
Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
Who this might be right for
Cytopaenia
Novartis Pharmaceuticals 21